🔗 Permalink

Inventor profile of:

Claude Leclerc

City:

Paris

Country:

France

Published Applications:

Last publication date:

2017-10-05

Top Assignees for applications by Claude Leclerc

The entities that hold a legal rights for patent applications filed by inventor Leclerc Claude:

Institut Pasteur 22 Paris, France
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE 10 PARIS, France
Institut National De La Sante Et De La Recherche Medicale (INSERM) 4 Paris, France
Institut National de la Sante et de la Recherche Medicale 3 Paris, France
Genticel 3 Labege-Innopole, France
INSTITUTE OF PHYSIOLOGY OF THE ASCR, V.V.I. 2 PRAGUE, Czech Republic
INSTITUTE OF MICROBIOLOGY OF THE ASCR, V.V.I. 2 PRAGUE, Czech Republic
INSTITUT PASTEUR 2 PARIS CEDEX 15, France
Institut Pasteur 2 Paris Cedex, France
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE 1 Paris Cedex 16, France
Centre National de la Recherche Scientique 1 Paris, France
Centre Mational de la Recherche Scientifique 1 Paris, France
Institut Pasteur, a corporation of France 1 Paris, France
Ludwig Institute for Cancer, a corporation of New York 1 New York, NY United States
PROYECTO DE BIOMEDICINA CIMA, S.L. 1 Navarra, Spain
Institut Nationale de la Sante et de la Recherche Medicale 1 Paris, -
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE 1 Paris Cedex, France
INSTITUTE OF MICROBIOLOGY OF THE ASCR., V.V.I. 1 Prague 4, Czech Republic
Ludwig Institute for Cancer 1 New York, NY United States
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHER. MED. 1 PARIS CEDEX 13, France
LUDWIG INSTITUT FOR CANCER RESEARCH 1 New York, NY United States

Recent patent applications by Leclerc Claude

Claude Leclerc from Paris, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2017-10-05

US20170283466A1

Chemistry; metallurgy

Method for preparing multiple antigen glycopeptide carbohydrate conjugates

#2 | 2016-12-29

US20160375119A1

Human necessities

Vectors for molecule delivery to CD11b expressing cells

#3 | 2016-07-28

US20160215039A1

Chemistry; metallurgy

AGENTS AND METHODS BASED ON THE USE OF THE EDA DOMAIN OF FIBRONECTIN

#4 | 2016-03-24

US20160083714A1

Chemistry; metallurgy

Mutant CyaA polypeptides and polypeptide derivatives suitable for the delivery of immunogenic molecules into a cell

#5 | 2015-10-15

US20150291665A1

Chemistry; metallurgy

Therapy of cancer based on targeting adaptive, innate and/or regulatory component of the immune response

#6 | 2014-12-25

US20140378652A9

Chemistry; metallurgy

METHOD FOR PREPARING MULTIPLE ANTIGEN GLYCOPEPTIDE CARBOHYDRATE CONJUGATES

#7 | 2014-08-14

US20140227323A1

Human necessities

RECOMBINANT ADENYLATE CYCLASE TOXIN OF BORDETELLA INDUCES T CELL RESPONSES AGAINST TUMORAL ANTIGENS

#8 | 2014-08-14

US20140227308A1

Human necessities

Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof

#9 | 2014-06-19

US20140171618A1

Chemistry; metallurgy

METHOD FOR PREPARING MULTIPLE ANTIGEN GLYCOPEPTIDE CARBOHYDRATE CONJUGATES

#10 | 2013-05-16

US20130121958A1

Human necessities

STREPTAVIDIN AND BIOTIN-BASED ANTIGEN DELIVERY SYSTEM

#11 | 2012-08-23

US20120214206A1

Human necessities

Vectors for molecule delivery to CD11b expressing cells

#12 | 2012-07-26

US20120189662A1

Human necessities

Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of BCG and

#13 | 2012-03-22

US20120071393A1

Chemistry; metallurgy

Mutant CyaA polypeptides and polypeptide derivatives suitable for the delivery of immunogenic molecules into a cell

#14 | 2012-03-01

US20120052083A1

Chemistry; metallurgy

MUTANT CyaA POLYPEPTIDES AND POLYPEPTIDE DERIVATIVES SUITABLE FOR THE DELIVERY OF IMMUNOGENIC MOLECULES INTO A CELL

#15 | 2011-07-14

US20110171244A1

Human necessities

Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof

#16 | 2011-03-15

US11713708

Modified adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereof

#17 | 2010-12-09

US20100310594A1

Chemistry; metallurgy

RECOMBINANT ADENYLATE CYCLASE TOXIN OF BORDETELLA INDUCES T CELL RESPONSES AGAINST TUMORAL ANTIGENS

#18 | 2010-10-28

US20100272707A1

Chemistry; metallurgy

Enzymatic large-scale synthesis of mucin glyconjugates, and immunogenic applications thereof

#19 | 2010-09-23

US20100239550A1

Chemistry; metallurgy

Mutant CyaA polypeptides and polypeptide derivatives suitable for the delivery of immunogenic molecules into a cell

#20 | 2010-06-17

US20100150999A1

Chemistry; metallurgy

THERAPY OF CANCER BASED ON TARGETING ADAPTIVE, INNATE AND/OR REGULATORY COMPONENT OF THE IMMUNE RESPONSE

#21 | 2009-12-24

US20090317854A1

Physics

Recombinant adenylate cyclase of BORDETELLA SP. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclase

#22 | 2009-09-03

US20090220532A1

Chemistry; metallurgy

Agents and methods based on the use of the EDA domain of fibronectin

#23 | 2009-05-07

US20090117143A1

Chemistry; metallurgy

Recombinant adenylate cyclase toxin of induces T cell responses against tumoral antigens

#24 | 2008-06-26

US20080152665A1

Chemistry; metallurgy

Therapy of cancer based on targeting adaptive, innate and/or regulatory component of the immune response

#25 | 2007-10-11

US20070237785A1

Human necessities

MULTIPLE ANTIGEN GLYCOPEPTIDE CARBOHYDRATE, VACCINE COMPRISING THE SAME AND USE THEREOF

#26 | 2007-05-03

US20070098730A1

Human necessities

Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof

#27 | 2007-03-29

US20070072266A1

Human necessities

Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof. therapeutic uses thereof

#28 | 2007-02-01

US20070026022A1

Human necessities

Recombinant adenylate cyclase toxin of Bordetella induces T cell responses against tumoral antigens

#29 | 2007-01-11

US20070009547A1

Chemistry; metallurgy

Modified ESAT-6 molecules and improved vaccine strains of BCG

#30 | 2006-12-21

US20060286613A1

Physics

Recombinant adenylate cyclase of Bordetella sp. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclase

#31 | 2006-07-20